Thursday
04.25.2024
8:16 PM
Login form
Search
Calendar
«  April 2024  »
SuMoTuWeThFrSa
 123456
78910111213
14151617181920
21222324252627
282930
Entries archive

My site

Main » Entries archive

LONDON-Friday, February 16th 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), has signed a minimum commitment contract valued at $500,000 with Global Radiodata Communications Ltd (“GRC” or “GRC Ltd”), who develop and supply mission-critical communication products and solutions, to provide high speed and resilient Ka-band satellite communications to defence and commercial operations.

Following successful trials, Avanti and GRC will deploy secure high data-rate communications across Avanti’s High Throughput Satellites, HYLAS 1 and HYLAS 2, using GRC’s very small (man-pack and SCYTALE) terminal solution.

The strategic partnership directly supports defence and security organisations in the provision of flexible, agile and portable satellite communications to the m ... Read more »

Views: 133 | Added by: uaeonlinenews | Date: 02.19.2018

RELIEF™ trial demonstrated statistically significant reductions in oral ulcers with apremilast 30 mg versus placebo through week 12

Significant improvements in key secondary endpoints, including oral ulcer pain, overall disease activity and quality of life

Data presented at the 2018 AAD Annual Meeting

Regulatory submissions in the U.S. and Japan planned for later this year

SUMMIT, N.J.-Sunday, February 18th 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s o ... Read more »

Views: 122 | Added by: uaeonlinenews | Date: 02.19.2018 | Comments (0)

 OSAKA, Japan-Sunday, February 18th 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- Takeda Pharmaceutical Company Limited (TOKYO: 4502), (“Takeda”) today announced it has become part of a select group of only thirteen (13) companies and one of two pharmaceuticals to receive global Top Employer® status for 2018. Established over 25 years ago, award certification is given annually by the Top Employers Institute to companies with exceptional employee offerings. The program is organized and designed by the Institute to recognize those that create optimal conditions for their employees to develop professionally and personally, and that achieve the highest standards of excellence for their people.

To be certified globally at least 20 countries, four regions and the applicant company’s global headquarters all needed to be certified by the Top Employer Institute, which Takeda has achieved this year.

“We’d like to thank the Top Employers ... Read more »

Views: 152 | Added by: africa-live | Date: 02.18.2018 | Comments (0)

HIGHLAND HEIGHTS, Ky.-Sunday, February 18th 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash.

A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018.

About General Cable

General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable produc ... Read more »

Views: 143 | Added by: uaeonlinenews | Date: 02.18.2018 | Comments (0)

LAUSANNE, Switzerland -Friday, February 16th 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia.

“It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success a ... Read more »

Views: 146 | Added by: africa-live | Date: 02.17.2018 | Comments (0)

IWATA, Japan -Friday, February 16th 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Yamaha Motor Co., Ltd. (TOKYO:7272) (ISIN:JP3942800008) is actively engaged in racing efforts all over the world in order to develop technologies and personnel under three main principles: raising the value of the Yamaha brand, acquiring advanced technologies and promoting the healthy spread of motorcycle racing.

In MotoGP last season, Yamaha notched up its 500th Grand Prix victory since it began racing in the World Championship in 1961. In addition, the GMT94 Yamaha Official EWC Team lifted the Endurance World Championship (EWC) title at the series’ Suzuka 8 Hours finale, where the Yamaha Factory Racing Team also took victory for the third year in a row.

Yamaha will be racing once again in 2018 aiming to surpass last year’s achievements, fielding Maverick Viñales and Valentino Rossi on the Movistar Yamaha MotoGP team in MotoGP, teams in various world championships like Worl ... Read more »

Views: 180 | Added by: uaeonlinenews | Date: 02.17.2018 | Comments (0)


Government Policies Impacting Delivery of Next-Generation Services Across Region;

Latin American Prices 60 Per Cent Higher Than Europe

BUENOS AIRES-Friday, February 16th 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- The GSMA today issued a new report, ‘Effective Spectrum Pricing in Latin America: Policies to support better quality and more affordable mobile services,’ highlighting that spectrum policies in Latin America are impacting the delivery of quality mobile services to consumers across the region.

The new report, which examines spectrum pricing trends in 15 countries across Latin America, underscores how decisions made by regulators on spectrum pricing can have a negative impact on the quality and cost of mobile broadband services. While auctions remain an effective means of awarding spectrum, regulators should adopt spectrum policies that focus on maximising long-term benefits for society, rather than driving up the cost of spectru ... Read more »

Views: 133 | Added by: africa-live | Date: 02.17.2018

LONDON-Thursday, February 15th 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- The GSMA today announced that McLaren Formula 1 Driver and double World Champion Fernando Alonso will be a featured speaker in a keynote session taking place on Tuesday, 27 February at Mobile World Congress in Barcelona.

Widely regarded as one of F1’s most talented drivers of all time, Alonso has also challenged himself by competing in the Indianapolis 500 and Daytona 24 Hours in the past year. This season, Alonso is focused on returning McLaren to the front of the grid and will also compete in the 24 Hours of Le Mans.

Alonso will be joined onstage by Zak Brown, Executive Director of McLaren Technology Group. In this session, Alonso and Brown will share their perspectives on the intersection of motorsport and cutting-edge mobile technology. McLaren increasingly relies on connectivity and sensors as a critical tool in optimising the performance of all of their cars, both F1 and road, a ... Read more »

Views: 130 | Added by: uaeonlinenews | Date: 02.17.2018 | Comments (0)

INGELHEIM, Germany -Friday, February 16th 2018 [ AETOS Wire ]

    'More Than Scleroderma: The Inside Story' provides real-life stories and education about the life-threatening disease

    New and truly inspiring patient stories are revealed

    Help raise awareness of this little-known disease by visiting www.morethanscleroderma.com

    “I’ve learned how to cope with this disease. There are many important things which I am still capable of doing.”– Anna, 36, living with scleroderma

(BUSINESS WIRE)-- Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com.

The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic S ... Read more »

Views: 142 | Added by: africa-live | Date: 02.17.2018 | Comments (0)

SUMMIT, N.J. -Thursday, February 15th 2018 [ AETOS Wire ]

Data shared at the 13th Congress of ECCO

Phase III program with OTEZLA (apremilast) in ulcerative colitis expected to begin in 2018

 

(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) announced that data from a randomized, placebo-controlled, multi-center, phase II clinical trial of apremilast in patients with active ulcerative colitis who had failed at least one conventional therapy but were naïve to biologic therapy were presented in an oral session today at the 13th Congress of ECCO in Vienna (Abstract OP006, 3:30 p.m. CET). The results showed that a higher proportion of patients taking apremilast 30 mg twice daily (BID) achieved clinical remission versus placebo (nominally significant, P<0.05). OTEZLA® (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4).

In the study, a total of 170 patients were randomized to placebo, apremilast 40 m ... Read more »

Views: 146 | Added by: uaeonlinenews | Date: 02.16.2018 | Comments (0)

« 1 2 ... 1341 1342 1343 1344 1345 ... 2388 2389 »